Other Major Cardiovascular Procedures with CC DRG Reimbursement

DRG 271 covers other major cardiovascular procedures performed during inpatient stays when a Complication or Comorbidity is present, reflecting higher resource intensity for complex non-coronary cardiac interventions and device-related operations. It matters for inpatient reimbursement because the presence of a Complication or Comorbidity increases the Diagnosis-Related Group assignment complexity and typically results in a higher Medicare payment weight compared with cases without such comorbid conditions.

DRG 271 Overview

DRG 271 encompasses inpatient admissions for other major cardiovascular procedures when a Complication or Comorbidity is present, typically including complex non-coronary cardiac surgeries or device-related interventions. This Diagnosis-Related Group groups cases with elevated resource use due to procedural complexity and the presence of a Complication or Comorbidity, which affects Medicare payment weight and hospital reimbursement. Understanding the clinical scope—procedural type plus concurrent complications—helps clarify why cases are classified here for payment purposes. The classification influences prospective payment adjustments under the Centers for Medicare & Medicaid Services rules for inpatient hospital reimbursement.

Acute perioperative management trials: randomized or pragmatic studies testing intraoperative and immediate postoperative strategies (eg, blood conservation techniques, enhanced myocardial protection protocols, or optimized hemodynamic monitoring algorithms) in patients undergoing complex non-coronary major cardiac or vascular procedures with significant comorbidity. These studies enroll patients admitted for high-risk procedures included in this DRG who have CC-level complications (eg, heart failure, renal insufficiency, severe arrhythmia) to evaluate short-term outcomes such as perioperative morbidity, transfusion requirements, and ICU length of stay. Results directly inform surgical teams, hospitalists, and payers about interventions that can reduce complications, resource use, and costs during the highest-acuity inpatient phase.
Comparative effectiveness research of procedural approaches and adjunctive technologies: observational cohorts and randomized comparisons that evaluate different surgical techniques, access strategies, or device adjuncts used in major cardiovascular operations not specified by other DRGs, stratified by comorbidity burden. These studies focus on patient-centered endpoints (eg, 30- and 90-day mortality, reoperation rates, readmissions) across heterogeneous populations with CCs such as chronic kidney disease or COPD to determine which approaches yield better outcomes in real-world practice. Findings help clinicians choose procedures that optimize clinical outcomes and help payers and hospital systems develop evidence-based care pathways and payment models tailored to patients with higher complication risk.
Post-discharge outcomes and care coordination studies: prospective cohorts and implementation trials assessing transitional care interventions, cardiac rehabilitation participation, medication adherence programs, and remote monitoring in survivors of major cardiovascular procedures who had CCs during the index admission. These studies examine readmission drivers, functional recovery, and long-term mortality in patients with comorbid conditions and complex discharge needs, testing interventions to reduce preventable readmissions and improve recovery. Evidence from this research is relevant to discharge planners, outpatient clinicians, and payers seeking to lower post-acute costs, improve quality metrics, and align inpatient care with value-based reimbursement goals.

Acute perioperative management trials: randomized or pragmatic studies testing intraoperative and immediate postoperative strategies (eg, blood conservation techniques, enhanced myocardial protection protocols, or optimized hemodynamic monitoring algorithms) in patients undergoing complex non-coronary major cardiac or vascular procedures with significant comorbidity. These studies enroll patients admitted for high-risk procedures included in this DRG who have CC-level complications (eg, heart failure, renal insufficiency, severe arrhythmia) to evaluate short-term outcomes such as perioperative morbidity, transfusion requirements, and ICU length of stay. Results directly inform surgical teams, hospitalists, and payers about interventions that can reduce complications, resource use, and costs during the highest-acuity inpatient phase.
Comparative effectiveness research of procedural approaches and adjunctive technologies: observational cohorts and randomized comparisons that evaluate different surgical techniques, access strategies, or device adjuncts used in major cardiovascular operations not specified by other DRGs, stratified by comorbidity burden. These studies focus on patient-centered endpoints (eg, 30- and 90-day mortality, reoperation rates, readmissions) across heterogeneous populations with CCs such as chronic kidney disease or COPD to determine which approaches yield better outcomes in real-world practice. Findings help clinicians choose procedures that optimize clinical outcomes and help payers and hospital systems develop evidence-based care pathways and payment models tailored to patients with higher complication risk.
Post-discharge outcomes and care coordination studies: prospective cohorts and implementation trials assessing transitional care interventions, cardiac rehabilitation participation, medication adherence programs, and remote monitoring in survivors of major cardiovascular procedures who had CCs during the index admission. These studies examine readmission drivers, functional recovery, and long-term mortality in patients with comorbid conditions and complex discharge needs, testing interventions to reduce preventable readmissions and improve recovery. Evidence from this research is relevant to discharge planners, outpatient clinicians, and payers seeking to lower post-acute costs, improve quality metrics, and align inpatient care with value-based reimbursement goals.

OpenPayer

Summary & Overview

Other Major Cardiovascular Procedures with CC: Inpatient Reimbursement Overview

DRG 271 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes